BiPAVE-001

Who Can Participate in the Study?

Age Group
Adults

Study Details

Full Title
Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors
Principal Investigator
Headshot of Niharika Bansal Mettu
Associate Professor of Medicine
Protocol Number
IRB: PRO00119499
NCT: NCT06635785
Phase
Phase I
ClinicalTrials.gov
Enrollment Status
OPEN TO ACCRUAL